Commentary: Significance of intratumoral genetic heterogeneity in neuroblastomas

被引：6

作者：

Brodeur, GM ^{[1
]}

机构：

[1] Childrens Hosp Philadelphia, Abramson Res Ctr, Div Oncol, Philadelphia, PA 19104 USA

来源：

MEDICAL AND PEDIATRIC ONCOLOGY | 2002年 / 38卷 / 02期

关键词：

D O I：

10.1002/mpo.1282.abs

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：112 / 113

页数：2

共 17 条

[1]

Ambros PF, 2001, MED PEDIATR ONCOL, V36, P1

[2]

Brodeur Garrett M., 1997, P761

[3] AMPLIFICATION OF N-MYC IN UNTREATED HUMAN NEUROBLASTOMAS CORRELATES WITH ADVANCED DISEASE STAGE [J].

BRODEUR, GM ;

SEEGER, RC ;

SCHWAB, M ;

VARMUS, HE ;

BISHOP, JM .

SCIENCE, 1984, 224 (4653) :1121-1124

[4] REVISIONS OF THE INTERNATIONAL CRITERIA FOR NEUROBLASTOMA DIAGNOSIS, STAGING, AND RESPONSE TO TREATMENT [J].

BRODEUR, GM ;

PRITCHARD, J ;

BERTHOLD, F ;

CARLSEN, NLT ;

CASTEL, V ;

CASTLEBERRY, RP ;

DEBERNARDI, B ;

EVANS, AE ;

FAVROT, M ;

HEDBORG, F ;

KANEKO, M ;

KEMSHEAD, J ;

LAMPERT, F ;

LEE, REJ ;

LOOK, AT ;

PEARSON, ADJ ;

PHILIP, T ;

ROALD, B ;

SAWADA, T ;

SEEGER, RC ;

TSUCHIDA, Y ;

VOUTE, PA .

JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (08) :1466-1477

[5]

BRODEUR GM, 1987, CANCER RES, V47, P4248

[6] INTERNATIONAL CRITERIA FOR DIAGNOSIS, STAGING, AND RESPONSE TO TREATMENT IN PATIENTS WITH NEURO-BLASTOMA [J].

BRODEUR, GM ;

SEEGER, RC ;

BARRETT, A ;

BERTHOLD, F ;

CASTLEBERRY, RP ;

DANGIO, G ;

DEBERNARDI, B ;

EVANS, AE ;

FAVROT, M ;

FREEMAN, AI ;

HAASE, G ;

HARTMANN, O ;

HAYES, FA ;

HELSON, L ;

KEMSHEAD, J ;

LAMPERT, F ;

NINANE, J ;

OHKAWA, H ;

PHILIP, T ;

PINKERTON, CR ;

PRITCHARD, J ;

SAWADA, T ;

SIEGEL, S ;

SMITH, EI ;

TSUCHIDA, Y ;

VOUTE, PA .

JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (12) :1874-1881

[7] Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma [J].

Caron, H ;

vanSluis, P ;

deKraker, J ;

Bokkerink, J ;

Egeler, M ;

Laureys, G ;

Slater, R ;

Westerveld, A ;

Voute, PA ;

Versteeg, R .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (04) :225-230

[8] The International Neuroblastoma Risk Groups (INRG): a preliminary report [J].

Castleberry, RP ;

Pritchard, J ;

Ambros, P ;

Berthold, F ;

Brodeur, GM ;

Castel, V ;

Cohn, SL ;

De Bernardi, B ;

Dicks-Mireaux, C ;

Frappaz, D ;

Haase, GM ;

Haber, M ;

Jones, DR ;

Joshi, VV ;

Kaneko, M ;

Kemshead, JT ;

Kogner, P ;

Lee, REJ ;

Matthay, KK ;

Michon, JM ;

Monclair, R ;

Roald, BR ;

Seeger, RC ;

Shaw, PJ ;

Shimada, H ;

Shuster, JJ .

EUROPEAN JOURNAL OF CANCER, 1997, 33 (12) :2113-2116

[9]

COHN SL, 1995, CANCER RES, V55, P721

[10] Neuroblastoma with focal MYCN amplification and bone marrow infiltration:: A staging and treatment dilemma [J].

Kerbl, R ;

Ambros, IM ;

Ambros, PF ;

Lackner, H ;

Dornbusch, HJ ;

Urban, CE .

MEDICAL AND PEDIATRIC ONCOLOGY, 2002, 38 (02) :109-111

← 1 2 →